ASXSF Elysee Development Corp (PK)

Remedent, Inc. (OTCBB: REMI), an international company specializing in the research, development, manufacturing of oral care and cosmetic dentistry products, today announced that it has signed an exclusive agreement with Accendo Healthcare Pte Ltd., a leading OTC distributor of healthcare products in Singapore, for the marketing and distribution of Glamsmile�, a revolutionary cosmetic dental system that substantially expands the consumer and professional dental market for veneers. Accendo agreed to a negotiated upfront payment and, in order to maintain its exclusivity in the Singapore market, Accendo further agreed to purchase and install a specified minimum number of Glamsmile� veneers annually. Both the upfront payment and the minimum number of Glamsmile� installations were related to the size of the Singapore market opportunity. Mr. Guy De Vreese, Chairman of Remedent, noted, �Our agreement with Accendo Healthcare, a longtime partner of Remedent in introducing new innovative dental products into Singapore, is significant in that it marks the first step by Remedent to expand acceptance of its Glamsmile� veneers into the Asian market, a very large and relatively untapped opportunity. We anticipate agreements with other Asian countries will quickly follow; a number of which are substantially larger than Singapore and could, therefore, require both larger upfront payments and higher minimum yearly Glamsmile� installations to maintain exclusivity.� About Remedent, Inc. Remedent, Inc., a publicly-traded company on the OTCBB, specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. With offices in California, Belgium and Singapore, Remedent distributes its products in more than 35 countries. For additional information, visit Remedent's web site at www.remedent.com. FORWARD-LOOKING STATEMENTS �Safe Harbor� Statement under the Private Securities Litigation Reform Act of 1995: The statements by Guy De Vreese, the statements regarding growth of the GlamsmileTM product line, optimism related to the business, expanding sales, the Asian market�and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company�s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company�s products. In addition, actual results could vary materially based on changes or slower growth in the oral care and cosmetic dentistry products market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in the dental industry; unexpected difficulties in penetrating the oral care and cosmetic dentistry products market; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company�s Securities and Exchange Commission filings under �risk factors� and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.